JP2022513326A5 - - Google Patents

Info

Publication number
JP2022513326A5
JP2022513326A5 JP2021542280A JP2021542280A JP2022513326A5 JP 2022513326 A5 JP2022513326 A5 JP 2022513326A5 JP 2021542280 A JP2021542280 A JP 2021542280A JP 2021542280 A JP2021542280 A JP 2021542280A JP 2022513326 A5 JP2022513326 A5 JP 2022513326A5
Authority
JP
Japan
Prior art keywords
pathogen
polypeptide
different
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2021542280A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022513326A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2019/052747 external-priority patent/WO2020065349A2/en
Publication of JP2022513326A publication Critical patent/JP2022513326A/ja
Publication of JP2022513326A5 publication Critical patent/JP2022513326A5/ja
Priority to JP2024179966A priority Critical patent/JP2024180560A/ja
Priority to JP2025129697A priority patent/JP2025163163A/ja
Withdrawn legal-status Critical Current

Links

JP2021542280A 2018-09-28 2019-09-27 ワクチンおよび方法 Withdrawn JP2022513326A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2024179966A JP2024180560A (ja) 2018-09-28 2024-10-15 ワクチンおよび方法
JP2025129697A JP2025163163A (ja) 2018-09-28 2025-08-01 ワクチンおよび方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1815956.6 2018-09-28
GB201815956 2018-09-28
PCT/GB2019/052747 WO2020065349A2 (en) 2018-09-28 2019-09-27 Vaccines and methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024179966A Division JP2024180560A (ja) 2018-09-28 2024-10-15 ワクチンおよび方法

Publications (2)

Publication Number Publication Date
JP2022513326A JP2022513326A (ja) 2022-02-07
JP2022513326A5 true JP2022513326A5 (https=) 2022-10-05

Family

ID=68501852

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021542280A Withdrawn JP2022513326A (ja) 2018-09-28 2019-09-27 ワクチンおよび方法
JP2024179966A Pending JP2024180560A (ja) 2018-09-28 2024-10-15 ワクチンおよび方法
JP2025129697A Pending JP2025163163A (ja) 2018-09-28 2025-08-01 ワクチンおよび方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2024179966A Pending JP2024180560A (ja) 2018-09-28 2024-10-15 ワクチンおよび方法
JP2025129697A Pending JP2025163163A (ja) 2018-09-28 2025-08-01 ワクチンおよび方法

Country Status (5)

Country Link
US (1) US20220040284A1 (https=)
EP (1) EP3856239A2 (https=)
JP (3) JP2022513326A (https=)
CN (2) CN113453710A (https=)
WO (1) WO2020065349A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021403658A1 (en) * 2020-12-16 2023-06-29 Molecular Partners Ag Recombinant cd3 binding proteins and their use
CA3211368A1 (en) * 2021-03-09 2022-09-15 Molecular Partners Ag Novel darpin based cd123 engagers
WO2023275538A1 (en) * 2021-06-28 2023-01-05 Diosynvax Ltd Beta-coronavirus vaccines
CN114807225B (zh) * 2022-04-26 2024-01-16 吉林大学 一种抗羊口疮和绵羊痘的重组dna疫苗及其重组质粒
CN117591664B (zh) * 2023-04-25 2024-12-13 上海任意门科技有限公司 一种数据挖掘方法、装置及存储介质
WO2025083402A1 (en) 2023-10-16 2025-04-24 Diosynvax Ltd Coronavirus vaccines
GB202315888D0 (en) 2023-10-17 2023-11-29 Diosynvax Ltd Influenza vaccines
DE102023130217A1 (de) * 2023-11-01 2025-05-08 Universität Leipzig, Körperschaft des öffentlichen Rechts Verfahren zur Bestimmung der Immunogenität eines Antigens
GB202404264D0 (en) * 2024-03-25 2024-05-08 Univ Regensburg Hemorrhagic fever vaccines
WO2026074282A1 (en) 2024-10-01 2026-04-09 Diosynvax Ltd. Influenza vaccines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1846439A2 (en) * 2005-01-31 2007-10-24 The Johns Hopkins University Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants
WO2013119683A1 (en) * 2012-02-07 2013-08-15 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Computationally optimized broadly reactive antigens for h3n2, h2n2, and b influenza viruses
EP3188752A2 (en) * 2014-09-03 2017-07-12 Bavarian Nordic A/S Recombinant modified vaccinia virus ankara (mva) filovirus vaccine
US10245313B2 (en) * 2014-10-24 2019-04-02 Versitech Limited DNA motif compounds and methods for inducing specific antibodies and cellular immunity
US11701418B2 (en) * 2015-01-12 2023-07-18 Geovax, Inc. Replication-deficient modified vaccinia Ankara (MVA) expressing Ebola virus glycoprotein (GP) and matrix protein (VP40)
EP3484507A1 (en) * 2016-07-15 2019-05-22 Janssen Vaccines & Prevention B.V. Methods and compositions for inducing protective immunity against a marburg virus infection

Similar Documents

Publication Publication Date Title
JP2022513326A5 (https=)
JP7326157B2 (ja) Ｈｂｖワクチン
KR102946697B1 (ko) 키메라 분자 및 그의 용도
KR102713707B1 (ko) 신규 다가 나노입자 기반 백신
CN110167585B (zh) 稳定化的第2组流感血凝素茎区三聚体及其用途
JP2022534282A5 (https=)
CN115246874B (zh) 一种重组新型冠状病毒s-rbd三聚体蛋白、其制备方法和应用
RU2019119272A (ru) Вирусная доставка неоантигенов
EP3191589B1 (en) Flavivirus virus like particle
CN113230395A (zh) 一种β冠状病毒抗原、β冠状病毒二联疫苗及其制备方法和应用
JP2020515272A5 (https=)
JP2016202185A (ja) ホモ二量体タンパク質コンストラクト
JP2023542297A5 (https=)
WO2023138334A1 (zh) 一种重组新型冠状病毒蛋白疫苗、其制备方法和应用
JP2024537250A5 (https=)
US20190201521A1 (en) Immunogenic composition
CN101257917A (zh) 针对黄病毒科病毒感染的嵌合多肽及其治疗应用
CN110248954A (zh) 在植物中产生可溶性hiv包膜三聚体
CN114269939A (zh) 汉坦病毒抗原组合物
JP2022540089A5 (https=)
US9907843B2 (en) Recombinant novirhabdovirus usable as an antigen vector
Martinez-Donato et al. Multimeric HCV E2 protein obtained from Pichia pastoris cells induces a strong immune response in mice
KR20230131439A (ko) 사스-코로나바이러스-2 감염증 예방용 재조합 발현 벡터 및 그 응용
WO2023138333A1 (zh) 一种重组新型冠状病毒蛋白疫苗、其制备方法和应用
JP2024523329A5 (https=)